Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Divests its shares of Epigeum

26 May 2015 07:01

RNS Number : 1235O
Imperial Innovations Group plc
26 May 2015
 



26 May 2015

 

Imperial Innovations Group plc

 

Divests its shares of Epigeum

 

Imperial Innovations Group plc (AIM: IVO, "Innovations", "the Group") announces the sale of its shares in e-learning portfolio company Epigeum Ltd. ("Epigeum" or "the Company") to Oxford University Press for £1.9 million in cash. Innovations owned a 17.8% equity stake in Epigeum, which was held in the books at a carrying value £0.5 million. The sale has therefore generated a gross profit on disposal of £1.4 million before revenue share (50%) with Imperial College London.

 

Epigeum is a provider of online courses designed to help universities and colleges to support their core activities in teaching, research, studying and leadership and management. The Company's courses are used by 230 Universities across 27 countries.

 

Oxford University Press is a department of the University of Oxford and the world's largest university press. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide.

 

Epigeum was spun out of Imperial College London and co-founded by Innovations in 2006. Innovations' Technology Transfer team supported the founding academic and management team with business planning and setting up of the company. Epigeum then generated revenues, rapidly becoming self-financing, and hence did not require funding as part of the Group's investment portfolio. However, by virtue of being instrumental in setting up the business, Innovations held founding equity in the business on inception.

 

Tony Hickson, Managing Director Technology Transfer at Imperial Innovations, said:

 

"Epigeum is a great example of one of our many successful spin-outs from Imperial College that are able to grow with ambition, without receiving venture funding from the Group.

 

"Prior to this transaction, it was part of our Organic Growth portfolio of around 30 companies, where instead of investing, we provide on-going support to promote organic growth and revenue generation."

 

For further information contact:

 

Imperial Innovations Group plc

020 3053 8834

Russ Cummings, Chief Executive Officer

Jon Davies, Director of Communications

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth Stanley/Alec Pratt

 

Cenkos Securities

020 7397 8900

Christopher Golden

Oxford University Press

Emma Duke

01865 353985

 

 

 

Notes to editors

 

About Imperial Innovations - www.imperialinnovations.co.uk 

 

Imperial Innovations Group plc creates, builds and invests in pioneering technologies developed from the academic research within the 'Golden Triangle' broadly bounded by London, Cambridge and Oxford, which is home to the UK's four leading research-intensive universities.

 

This area is home to many new technology companies through its proximity to the academic communities of Imperial College London, the University of Cambridge, the University of Oxford and University College London, as well as other leading research institutions.

 

Imperial College London, the University of Cambridge, the University of Oxford and University College London collectively have research income of £1.4 billion per annum and are ranked as four of the top ten Universities in the world (source: QS World University Rankings 2014/15).

 

Innovations supports scientists and entrepreneurs in the commercialisation of their ideas through the licensing of intellectual property, by leading the formation of new companies, providing facilities in the early stages, providing investment and encouraging co-investment to accelerate development, providing operational expertise and recruiting high-calibre management teams. It also runs an incubator in London that is the initial home for many of its technology spin-outs.

 

Since admission of its shares to trading on AIM in 2006, Innovations has raised more than £346.0 million of equity from investors, which has enabled it to invest in some of the most exciting spin-outs to come out of UK academic research. In addition, the Group has a £30.0 million loan facility from the European Investment Bank (EIB) for investment in biotech and therapeutics businesses.

 

During the period from admission on AIM up until 31 January 2015, Innovations has invested a total of £198.3 million across its portfolio companies, which have raised collectively investment of £926.8 million rising to £1.0 billion including post period end investments and commitments.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXSAAALSEFF
Date   Source Headline
27th Nov 20177:00 amRNSExercise of share options
27th Nov 20177:00 amRNSIssue of Equity
13th Nov 20177:01 amRNSBoard changes following cancellation of admission
13th Nov 20177:00 amRNSNotice of cancellation of admission to AIM
27th Oct 201710:54 amRNSPosting of Annual Report
26th Oct 20173:50 pmRNSIssue of Equity
18th Oct 201710:30 amRNSOffer Update; Appointment of Prof. David Begg
18th Oct 20179:38 amRNSUpdated recommendation by Touchstone Innovations
18th Oct 20177:00 amRNSOffer Update - Wholly Unconditional
17th Oct 20179:10 amRNSGrant of share options
17th Oct 20177:36 amRNSOffer Update - CMA clearance and Offer timetable
16th Oct 201710:54 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
9th Oct 20179:58 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
9th Oct 20177:00 amRNSOffer Update
5th Oct 20178:30 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
4th Oct 20177:00 amRNSTouchstone invests £1.4m in Featurespace round
2nd Oct 201710:32 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
29th Sep 20178:29 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
25th Sep 20179:15 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
21st Sep 20178:56 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
18th Sep 20177:00 amRNSOffer Update
13th Sep 20179:33 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
13th Sep 20177:00 amRNSFinal Results
12th Sep 20171:48 pmRNSForm 8.3 - Touchstone Innovations plc
12th Sep 20171:46 pmRNSForm 8.3 - Touchstone Innovations plc
12th Sep 201711:50 amRNSForm 8.3 - Touchstone Innovations Plc
12th Sep 201710:52 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
12th Sep 20177:00 amRNSTouchstone commits funds to Ieso Digital Health
11th Sep 20179:41 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
8th Sep 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
8th Sep 20178:51 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations PLC
7th Sep 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
7th Sep 20178:57 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations PLC
30th Aug 20176:21 pmRNSUpdate on Offer for Touchstone Innovations plc
25th Aug 201710:14 amRNSUpdate on Offer for Touchstone and Capital Raising
25th Aug 20179:56 amRNSStatement re: Offer timetable extended
21st Aug 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
17th Aug 20177:00 amRNSFurther re Capital Raising
16th Aug 20173:12 pmRNSForm 8.3 - IP Group Plc
15th Aug 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
1st Aug 20177:00 amRNSPublication of Response Circular
28th Jul 20172:21 pmRNSForm 8.3 - IP Group Plc
27th Jul 20172:52 pmRNSForm 8.3 - IP Group Plc
26th Jul 20172:20 pmRNSForm 8.3 - IP Group Plc
25th Jul 20175:38 pmRNSStatement re clarification of offer for Touchstone
25th Jul 201712:16 pmRNSForm 8.3 - Touchstone Innovations Plc
21st Jul 201712:43 pmRNSForm 8.3 - Touchstone Innovations Plc
20th Jul 201711:35 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
19th Jul 201711:42 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
19th Jul 201711:14 amRNSForm 8.3 - Touchstone Innovations Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.